Osaka, Japan

Yoichiro Kawai

This inventor holds 1 USPTO granted patent. Top assignee: Funai Yakuhin Kogyo Kabushiki Kaisha. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoichiro Kawai. Retrieved from https://idiyas.com/inventor/yoichiro-kawai-6cwqnnn2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoichiro Kawai: Innovator in Anti-Tumor Agents

Introduction

Yoichiro Kawai is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor agents. His innovative work has led to the creation of a unique compound that possesses strong anti-tumor activity with minimal toxicity.

Latest Patents

Kawai holds a patent for 2'-Deoxy-3',5'-di-O-alkylcarbonyl-5-fluorouridine derivatives. This patent describes a process for synthesizing these derivatives, which are represented by a specific general formula. The compounds are characterized by their strong anti-tumor activity and are particularly useful for oral administration. The derivatives are prepared by acylating a 2'-deoxy-3',5'-di-O-alkylcarbonyl-5-fluorouridine with corresponding benzoyl halides.

Career Highlights

Kawai is associated with Funai Yakuhin Kogyo Kabushiki Kaisha, where he continues to work on innovative pharmaceutical solutions. His research focuses on developing compounds that can effectively combat tumors while minimizing side effects.

Collaborations

Kawai has collaborated with esteemed colleagues such as Setsuro Fujii and Bompei Yasui. Their combined expertise has contributed to advancements in the field of anti-tumor research.

Conclusion

Yoichiro Kawai's contributions to the development of anti-tumor agents highlight his innovative spirit and dedication to improving cancer treatment. His work continues to inspire advancements in pharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…